Cardan Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14,125
| Closed | -$1.01M | – | 189 |
|
|
2018
Q4 | $1.01M | Buy |
14,125
+1,430
| +11% | +$103K | 0.18% | 92 |
|
|
2018
Q3 | $1.22M | Buy |
12,695
+600
| +5% | +$57.5K | 0.19% | 86 |
|
|
2018
Q2 | $1.15M | Buy |
12,095
+1,036
| +9% | +$98.6K | 0.19% | 84 |
|
|
2018
Q1 | $970K | Buy |
+11,059
| New | +$970K | 0.16% | 87 |
|
|
2017
Q4 | – | Sell |
-7,680
| Closed | -$665K | – | 127 |
|
|
2017
Q3 | $665K | Buy |
7,680
+200
| +3% | +$17.3K | 0.13% | 76 |
|
|
2017
Q2 | $577K | Buy |
7,480
+106
| +1% | +$8.18K | 0.11% | 77 |
|
|
2017
Q1 | $511K | Buy |
7,374
+995
| +16% | +$69K | 0.11% | 79 |
|
|
2016
Q4 | $378K | Buy |
6,379
+1,997
| +46% | +$118K | 0.08% | 82 |
|
|
2016
Q3 | $290K | Buy |
+4,382
| New | +$290K | 0.06% | 90 |
|